MorphoSys AG (MOR)
18.04
-0.09
(-0.50%)
USD |
NASDAQ |
Apr 26, 16:00
18.04
0.00 (0.00%)
After-Hours: 20:00
MorphoSys Revenue (TTM): 257.99M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 257.99M |
| September 30, 2023 | 277.88M |
| June 30, 2023 | 304.82M |
| March 31, 2023 | 310.16M |
| December 31, 2022 | 289.76M |
| September 30, 2022 | 266.77M |
| June 30, 2022 | 218.94M |
| March 31, 2022 | 201.70M |
| December 31, 2021 | 212.04M |
| September 30, 2021 | 194.50M |
| June 30, 2021 | 171.64M |
| March 31, 2021 | 145.83M |
| December 31, 2020 | 366.20M |
| September 30, 2020 | 335.49M |
| June 30, 2020 | 323.64M |
| March 31, 2020 | 342.30M |
| December 31, 2019 | 80.46M |
| September 30, 2019 | 80.15M |
| June 30, 2019 | 130.28M |
| March 31, 2019 | 101.05M |
| December 31, 2018 | 89.09M |
| September 30, 2018 | 110.29M |
| June 30, 2018 | 63.98M |
| March 31, 2018 | 67.21M |
| December 31, 2017 | 76.38M |
| Date | Value |
|---|---|
| September 30, 2017 | 57.28M |
| June 30, 2017 | 53.50M |
| March 31, 2017 | 54.31M |
| December 31, 2016 | 55.04M |
| September 30, 2016 | 54.47M |
| June 30, 2016 | 53.11M |
| March 31, 2016 | 52.85M |
| December 31, 2015 | 118.96M |
| September 30, 2015 | 126.75M |
| June 30, 2015 | 135.93M |
| March 31, 2015 | 142.57M |
| December 31, 2014 | 84.88M |
| September 30, 2014 | 83.17M |
| June 30, 2014 | 81.79M |
| March 31, 2014 | 102.57M |
| December 31, 2013 | 103.15M |
| September 30, 2013 | 105.03M |
| June 30, 2013 | 98.47M |
| March 31, 2013 | 73.86M |
| December 31, 2012 | 66.82M |
| September 30, 2012 | 43.18M |
| June 30, 2012 | 53.56M |
| March 31, 2012 | 63.25M |
| December 31, 2011 | 114.40M |
| September 30, 2011 | 149.56M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
80.15M
Minimum
Sep 2019
366.20M
Maximum
Dec 2020
237.40M
Average
257.99M
Median
Dec 2023
Revenue (TTM) Benchmarks
| Incyte Corp | 3.696B |
| Novartis AG | 49.92B |
| Immatics NV | 58.49M |
| Affimed NV | 8.941M |
| InflaRx NV | -- |